Ketalar

Ketalar is a brand name of ketamine, approved by the FDA in the following formulation(s):

KETALAR (ketamine hydrochloride - injectable; injection)

• 
  Manufacturer: JHP PHARMS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): EQ 100MG BASE/ML ^[RLD][AP], EQ 10MG BASE/ML ^[RLD][AP], EQ 50MG BASE/ML ^[RLD][AP]

Has a generic version of Ketalar been approved?

Yes. The following products are equivalent to Ketalar:

ketamine hydrochloride injectable; injection

• 
  Manufacturer: BEDFORD
  
  Approval date: March 22, 1996
  
  Strength(s): EQ 100MG BASE/ML ^[AP], EQ 50MG BASE/ML ^[AP]


• 
  Manufacturer: BIONICHE PHARMA
  
  Approval date: December 28, 2001
  
  Strength(s): EQ 50MG BASE/ML ^[AP]


• 
  Manufacturer: BIONICHE PHARMA
  
  Approval date: October 25, 2002
  
  Strength(s): EQ 100MG BASE/ML ^[AP]


• 
  Manufacturer: BIONICHE PHARMA
  
  Approval date: September 30, 2008
  
  Strength(s): EQ 10MG BASE/ML ^[AP]


• 
  Manufacturer: HOSPIRA
  
  Approval date: June 27, 1996
  
  Strength(s): EQ 100MG BASE/ML ^[AP], EQ 50MG BASE/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ketalar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ketalar.

See also...

• Ketalar Consumer Information (Wolters Kluwer)
• Ketalar Consumer Information (Cerner Multum)
• Ketamine Consumer Information (Wolters Kluwer)
• Ketamine Consumer Information (Cerner Multum)